Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lemaitre Vascular (NQ: LMAT ) 94.88 +6.49 (+7.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lemaitre Vascular < Previous 1 2 3 Next > Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday November 01, 2024 Via Benzinga In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular November 01, 2024 Via Benzinga This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday October 15, 2024 Via Benzinga Analyst Scoreboard: 4 Ratings For LeMaitre Vascular October 15, 2024 Via Benzinga LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024 August 01, 2024 LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Navigating 4 Analyst Ratings For LeMaitre Vascular May 31, 2024 Via Benzinga Recap: LeMaitre Vascular Q4 Earnings February 27, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga A Preview Of LeMaitre Vascular's Earnings February 26, 2024 Via Benzinga Staar Surgical Stock Earns RS Rating Upgrade June 27, 2024 On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. Via Investor's Business Daily Stryker Stock Sees RS Rating Treks Higher To 71 May 29, 2024 Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. Via Investor's Business Daily Sell In May And Go Away? – April Dividend Income Report May 27, 2024 The “Sell in May and Go Away” adage is wrong for most investors. Via Talk Markets LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 April 30, 2024 On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78. Via Investor's Business Daily Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know February 28, 2024 Via Benzinga 5 Analysts Have This to Say About LeMaitre Vascular October 23, 2023 Via Benzinga Sidoti Events, LLC's Virtual December Small-Cap Conference December 05, 2023 Via ACCESSWIRE Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating September 06, 2023 Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a Via Benzinga Looking for Dividend Growth? Buy This Little-Known Healthcare Stock September 01, 2023 The healthcare company's dividend has soared in recent years. Via The Motley Fool 2 Healthcare Stocks That Could Help Make You a Fortune August 26, 2023 These companies did well for shareholders over the last 10 years and have the potential to keep the growth going. Via The Motley Fool Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year August 23, 2023 Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 September 06, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 August 03, 2023 Via Benzinga Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday August 03, 2023 Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in... Via Benzinga 3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential June 28, 2023 The smallest stocks have been trailing their larger counterparts. Here are three top micro-cap stocks to ride the asset class' resurgence. Via InvestorPlace Beat the Dow Jones With This Unstoppable Dividend Stock June 19, 2023 The wealth created by this medical devices company for its investors over the past decade far exceeds what the Dow Jones generated. Via The Motley Fool Sidoti Events, LLC's Virtual June Small-Cap Conference June 13, 2023 Via ACCESSWIRE Is This Healthcare Stock a Buy for Dividend Growth Investors? May 17, 2023 This medical device maker has crushed the S&P 500 index in the past 10 years. Via The Motley Fool Why Shares of LeMaitre Vascular Are Up Wednesday May 03, 2023 LeMaitre announced first-quarter earnings and guidance numbers. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 May 03, 2023 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
